Identification of Hub Genes Associated with Outcome of Clear Cell Renal Cell Carcinoma

Overview

Journal Oncol Lett

Specialty Oncology

Date 2020 Mar 29

PMID 32218839

Citations 7

Authors

Rengui Li

Lei Wang

Xiao Wang

Rong-Xin Geng

Ning Li

Xiu-Heng Liu

Affiliations

Soon will be listed here.

Abstract

Clear cell renal cell carcinoma (ccRCC) is one of the most common tumor types of the urinary system. Bioinformatics tools have been used to identify new biomarkers of ccRCC and to explore the mechanisms underlying development and progression of ccRCC. The present study analyzed the differentially expressed genes (DEGs) associated with RCC using data obtained from Gene Expression Omnibus datasets and GEO2R software. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of these DEGs was performed and analyzed using the Database for Annotation, Visualization and Integrated Discovery. A protein-protein interaction (PPI) network was constructed using the Search Tool for the Retrieval of Interacting Genes to identify the hub genes, defined as the genes with the highest degree of interrelation. Subsequently, differential expression and survival analyses of hub genes was performed using The Cancer Genome Atlas database and Gene Expression Profiling Interactive Analysis (GEPIA) online tool. Using GEO2R, 1,650 DEGs were identified, including 743 upregulated and 907 downregulated genes. GO and KEGG pathway analyses indicated that the upregulated DEGs were primarily involved in blood vessel and vasculature development, whereas downregulated DEGs were primarily involved in organic acid metabolic processes and carboxylic acid metabolic processes. Subsequently, important modules were identified in the PPI network using Cytoscape's Molecular Complex Detection. The 15 most connected hub genes were identified among DEGs, including glycine decarboxylase (GLDC), enolase 2 (ENO2) and topoisomerase II alpha. GEPIA revealed the association between expression levels of hub genes and survival. Specifically, GLDC and ENO2 were associated with the prognosis of patients with RCC and thus, the effects of GLDC and ENO2 involvement in renal cancer were investigated . GLDC and ENO2 affected the proliferation and apoptosis of renal cancer cells. These hub genes may reveal a new mechanism underlying development or progression of RCC and identify new markers for its diagnosis and prognosis.

Citing Articles

Glycine Decarboxylase Regulates Renal Carcinoma Progression via Interferon Stimulated Gene Factor 3-Mediated Pathway.

Pham T, Kim M, Nguyen T, Park J, Kim J, Seo J Int J Biol Sci. 2025; 21(2):772-788.

PMID: 39781465 PMC: 11705630. DOI: 10.7150/ijbs.104458.

Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma.

Ajadee A, Mahmud S, Hossain M, Ahmmed R, Ali M, Reza M PLoS One. 2024; 19(9):e0310843.

PMID: 39348357 PMC: 11441673. DOI: 10.1371/journal.pone.0310843.

Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis.

Peng L, Cao Z, Wang Q, Fang L, Yan S, Xia D Front Oncol. 2022; 12:963483.

PMID: 36313709 PMC: 9606658. DOI: 10.3389/fonc.2022.963483.

MicroRNAs Promote the Progression of Sepsis-Induced Cardiomyopathy and Neurovascular Dysfunction Through Upregulation of NF-kappaB Signaling Pathway-Associated HDAC7/ACTN4.

Luo Q, Ma H, Guo E, Yu L, Jia L, Zhang B Front Neurol. 2022; 13:909828.

PMID: 35756932 PMC: 9218607. DOI: 10.3389/fneur.2022.909828.

Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.

Martins-da-Silva A, Baroni M, Salomao K, das Chagas P, Bonfim-Silva R, Geron L Cell Mol Neurobiol. 2022; 43(2):813-826.

PMID: 35366170 PMC: 11415171. DOI: 10.1007/s10571-022-01217-4.

References

Geng R, Li N, Xu Y, Liu J, Yuan F, Sun Q . Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis. Dis Markers. 2018; 2018:3215958. PMC: 6199874. DOI: 10.1155/2018/3215958. View

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

Trevisani F, Larcher A, Cinque A, Capitanio U, Ripa F, Vago R . The Association of Uromodulin Genotype with Renal Cancer Aggressiveness. Eur Urol Focus. 2017; 5(2):262-265. DOI: 10.1016/j.euf.2017.04.009. View

Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

Nagy A, Lanczky A, Menyhart O, Gyorffy B . Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018; 8(1):9227. PMC: 6003936. DOI: 10.1038/s41598-018-27521-y. View

Liao S, Aurelio O, Jan K, Zavada J, Stanbridge E . Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res. 1997; 57(14):2827-31. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

Gassenmaier M, Chen D, Buchner A, Henkel L, Schiemann M, Mack B . CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis. Stem Cells. 2013; 31(8):1467-76. DOI: 10.1002/stem.1407. View

Duran I, Lambea J, Maroto P, Gonzalez-Larriba J, Flores L, Granados-Principal S . Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action. Target Oncol. 2016; 12(1):19-35. DOI: 10.1007/s11523-016-0463-4. View

10.

Khraim W, Abu-Libdeh B, Ayesh S, Dweikat I . Clinical heterogeneity of glycine encephalopathy in three Palestinian siblings: A novel mutation in the glycine decarboxylase (GLDC) gene. Brain Dev. 2017; 39(7):601-605. DOI: 10.1016/j.braindev.2017.03.005. View

11.

Yan T, Skaftnesmo K, Leiss L, Sleire L, Wang J, Li X . Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. BMC Cancer. 2011; 11:524. PMC: 3259117. DOI: 10.1186/1471-2407-11-524. View

12.

Wozniak M, Le Calvez-Kelm F, Abedi-Ardekani B, Byrnes G, Durand G, Carreira C . Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States. PLoS One. 2013; 8(3):e57886. PMC: 3589490. DOI: 10.1371/journal.pone.0057886. View

13.

Li G, Cuilleron M, Gentil-Perret A, Cottier M, Passebosc-Faure K, Lambert C . Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma. Clin Cancer Res. 2003; 9(17):6441-6. View

14.

Kim S, Jung W, Koo J . Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes. PLoS One. 2014; 9(6):e101004. PMC: 4076239. DOI: 10.1371/journal.pone.0101004. View

15.

Pan Q, Shai O, Lee L, Frey B, Blencowe B . Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008; 40(12):1413-5. DOI: 10.1038/ng.259. View

16.

Laviolette L, Mermoud J, Calvo I, Olson N, Boukhali M, Steinlein O . Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein. Nat Commun. 2017; 8:15866. PMC: 5493755. DOI: 10.1038/ncomms15866. View

17.

Li G, Cuilleron M, Cottier M, Gentil-Perret A, Lambert C, Genin C . The use of MN/CA9 gene expression in identifying malignant solid renal tumors. Eur Urol. 2006; 49(2):401-5. DOI: 10.1016/j.eururo.2005.10.025. View

18.

Zhang T, Niu X, Liao L, Cho E, Yang H . The contributions of HIF-target genes to tumor growth in RCC. PLoS One. 2013; 8(11):e80544. PMC: 3832366. DOI: 10.1371/journal.pone.0080544. View

19.

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

20.

Rodriguez-Benitez V, Arranz J, Mata C, Perez-Navero J, Gil-Campos M . [A new mutation in the GLDC gene in non-ketotic hyperglycinaemia]. An Pediatr (Barc). 2011; 80(1):e7-8. DOI: 10.1016/j.anpedi.2011.11.002. View